The Evolution of Precision Diagnostics in Advancing Treatment Strategies of Solid Tumors

Sponsored by: Covaris

Speakers

Jeffrey Conroy

Head of Science, OmniSeq Inc., Executive Director, LabCorp
BIOGRAPHY
Eugenio Daviso, Ph.D.

VP Solutions, Covaris
BIOGRAPHY

Event Date & Time

Date: May 24, 2023

Time: 8:00 AM (PDT), 11:00 AM (EDT), 5:00 PM (CEST)

Abstract

Recent advances in multi-omic approaches, including genomics, transcriptomics, and proteomics, enable a more comprehensive description of the tumor. This promises to accelerate the development of precision medicine, but also presents challenges for diagnostic laboratories struggling to integrate this complex workflow into an efficient, scalable and robust service offering. This talk will highlight best practices, systems and innovations necessary for successful implementation of a Comprehensive Genomic and Immune Profiling (CGIP) assay to advance molecularly informed treatment decisions for cancer patients.

Learning Objectives

Challenges and opportunities in providing precision treatment options for advanced stage cancer patients
Innovations leading to broad-panel NGS-based tumor profiling and actionable data for better treatment decision making
Understand the clinical utility of Comprehensive Genomic and Immune Profiling (CGIP) with a review of 10,000 real-world cases

Webinars will be available for unlimited on-demand viewing after live event.

The Evolution of Precision Diagnostics in Advancing Treatment Strategies of Solid Tumors

Jeffrey Conroy

Eugenio Daviso, Ph.D.